Kornitzer Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-355,960
Closed -$12.1M 548
2021
Q3
$12.1M Buy
355,960
+10,000
+3% +$319K 0.19% 204
2021
Q2
$12.7M Buy
345,960
+1,200
+0.3% +$46.5K 0.19% 199
2021
Q1
$15.5M Buy
344,760
+91,950
+36% +$4.28M 0.25% 152
2020
Q4
$14.4M Buy
252,810
+36,225
+17% +$2.15M 0.24% 147
2020
Q3
$11.1M Buy
216,585
+22,750
+12% +$1.11M 0.22% 161
2020
Q2
$11.6M Sell
193,835
-1,390
-0.7% -$74.4K 0.23% 152
2020
Q1
$8.04M Buy
195,225
+34,370
+21% +$1.91M 0.19% 169
2019
Q4
$10M Sell
160,855
-47,899
-23% -$2.28M 0.18% 172
2019
Q3
$7.08M Sell
208,754
-3,995
-2% -$118K 0.13% 216
2019
Q2
$4.8M Sell
212,749
-870
-0.4% -$20.4K 0.08% 253
2019
Q1
$4.96M Sell
213,619
-150
-0.1% -$3.93K 0.09% 250
2018
Q4
$4.49M Buy
213,769
+25,410
+13% +$625K 0.09% 244
2018
Q3
$7.29M Hold
188,359
0.12% 220
2018
Q2
$7.41M Sell
188,359
-4,485
-2% -$132K 0.12% 208
2018
Q1
$3.87M Sell
192,844
-18,255
-9% -$462K 0.07% 264
2017
Q4
$4.79M Buy
211,099
+96,749
+85% +$1.89M 0.08% 246
2017
Q3
$2.17M Buy
+114,350
New +$2.09M 0.04% 305

Other funds holding DCPH

Kornitzer Capital Management's DCPH Position: Q4 2021 in Review

Kornitzer Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 355,960 shares — an estimated $12.1M sold.

Kornitzer Capital Management first reported a position in DCPH in Q3 2017 and held it in 17 quarters. The position peaked at $15.5M in Q1 2021. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

  • Kornitzer Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Kornitzer Capital Management sold 355,960 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $12.1M.
  • Kornitzer Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 17 quarters.
  • Kornitzer Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $15.5M in Q1 2021.
  • 140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Kornitzer Capital Management's 13F filing for Q4 2021, filed 1 Feb 2022.